Video Show

CAT # Product Name Description
CPD2802 Ingliforib; CP 368296 Ingliforib, also known as CP-368296, is a novel glycogen phosphorylase inhibitor. Ingliforib has antihyperglycemic and cardioprotective properties. Ingliforib inhibits glycogen phosphorylase, the rate-limiting enzyme in glycogenolysis, thereby preventing the release of glucose-1 phosphate from a glycogen molecule in liver. This agent also inhibits glycogen phosphorylase in cardiac muscle and may protect the heart from myocardial ischemic injury by preserving glycogen content and improving glycolytic-oxidative coupling
CPD111648 Sovilnesib; Sovilnesibum; AMG 650 Sovilnesib (AMG 650) is an orally effective Kinesin like protein KIF18A inhibitor.
CPDP802995 (S)-Bexicaserin
CPDM400440 3-methyl-4-((1-methyl-1H-benzo[d]imidazol-5-yl)...
CPDA602231 JNJ-37822681 JNJ-37822681 is a novel, potent, specific, centrally active, and fast-dissociating D(2) antagonist with optimal brain disposition. J
CPD100591 PF-06372222; GPCR modulator-1 GPCR modulator-1 is a negative allosteric modulator of GLP receptors.
CPDP803503 (R)-3-((6-fluoropyridin-3-yl)methyl)-1-(3-(pyri...
LVX0006 SARM1-IN-5 SARM1-IN-5 (compound 1-23-a) is a SARM1 inhibitor.
CPD109963 Crinecerfont; SSR125543 Crinecerfont (SSR-125543) is an effective, orally active, non peptide CRF1 receptor antagonist.
CPDP803114 STING agonist-20 STING agonist 20 (compound 95) is an effective STING agonist.
CPDM400438 tert-Butyl-3-(2-chloro-N-(3,4-difluorobenzyl)ac...
CPDM400232 6-[4-(Trifluoromethyl)-1H-imidazol-1-yl]-3-pyri...
N-[4-[(S)-(3,3-Dimethylcyclobutyl)[[6-[4-(trifl...
CPDM400437 Ethyl 4-[(3,3-dimethylcyclobutyl)carbonyl]benzoate
CPDM400241 tert-butyl (R)-2-methyl-1,4-diazepane-1-carboxy...
CPDP803488 tert-butyl (S)-2-methyl-1,4-diazepane-1-carboxy...
CPDP803490 tert-butyl (R)-3-methyl-1,4-diazepane-1-carboxy...
CPDP803006 N-[(1S)-1-[3-Chloro-5-fluoro-2-[[[2-methyl-4-(1...
CPDM400433 2-amino-5-(2,2,2-trifluoroethyl)thiophene-3-car...
CPDP802256 TREM2 agonist-2
CPDM400370 7-Chloro-5-(4-chloro-2-fluorophenyl)-2,3-dimeth...
CPDM400373 5,7-dichloro-2,3-dimethylpyrido[3,4-b]pyrazine
CPDP803465 5-(4-Chloro-2-fluorophenyl)-2,3-dimethyl-7-[(2S...
CPD112857 Divarasib; GDC6036; RG6330 Divarasib (GDC-6036) is a KRAS G12C inhibitor with oral bioavailability and selectivity.
CPDM400430 2-Chloro-5-fluoro-4-[(4-methoxybenzyl)oxy]pyrim...
CPDM400329 6-morpholinoquinoline-4-carboxylic acid
CPDM400330 ethyl 6-morpholinoquinoline-4-carboxylate
CPDM400331 ethyl 6-bromoquinoline-4-carboxylate
CPDS101632 6-bromoquinoline-4-carboxylic acid
CPDM400327 (R)-3-glycylthiazolidine-4-carbonitrile

Contact Us

Inquiry

Latest News

  • Top 7 Trends In Pharmaceutical Research In 2018

    Top 7 Trends In Pharmaceutical Research I...

      Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...

  • ARS-1620: A promising new inhibitor for KRAS-mutant cancers

    ARS-1620: A promising new inhibitor for K...

    According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be...

  • AstraZeneca receives regulatory boost for oncology drugs

    AstraZeneca receives regulatory boost for...

    AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

WhatsApp Online Chat !